1. Home
  2. MRVI vs BKT Comparison

MRVI vs BKT Comparison

Compare MRVI & BKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • BKT
  • Stock Information
  • Founded
  • MRVI 2014
  • BKT 1988
  • Country
  • MRVI United States
  • BKT United States
  • Employees
  • MRVI N/A
  • BKT N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • BKT Investment Bankers/Brokers/Service
  • Sector
  • MRVI Health Care
  • BKT Finance
  • Exchange
  • MRVI Nasdaq
  • BKT Nasdaq
  • Market Cap
  • MRVI 262.9M
  • BKT 247.8M
  • IPO Year
  • MRVI 2020
  • BKT N/A
  • Fundamental
  • Price
  • MRVI $1.98
  • BKT $11.69
  • Analyst Decision
  • MRVI Hold
  • BKT
  • Analyst Count
  • MRVI 9
  • BKT 0
  • Target Price
  • MRVI $6.54
  • BKT N/A
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • BKT 67.9K
  • Earning Date
  • MRVI 05-12-2025
  • BKT 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • BKT 8.97%
  • EPS Growth
  • MRVI N/A
  • BKT N/A
  • EPS
  • MRVI N/A
  • BKT N/A
  • Revenue
  • MRVI $259,185,000.00
  • BKT N/A
  • Revenue This Year
  • MRVI N/A
  • BKT N/A
  • Revenue Next Year
  • MRVI $14.23
  • BKT N/A
  • P/E Ratio
  • MRVI N/A
  • BKT N/A
  • Revenue Growth
  • MRVI N/A
  • BKT N/A
  • 52 Week Low
  • MRVI $1.67
  • BKT $10.55
  • 52 Week High
  • MRVI $11.56
  • BKT $12.92
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 43.17
  • BKT 55.42
  • Support Level
  • MRVI $1.96
  • BKT $11.49
  • Resistance Level
  • MRVI $2.16
  • BKT $11.73
  • Average True Range (ATR)
  • MRVI 0.13
  • BKT 0.13
  • MACD
  • MRVI 0.04
  • BKT 0.02
  • Stochastic Oscillator
  • MRVI 47.67
  • BKT 73.08

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About BKT BlackRock Income Trust Inc. (The)

Blackrock Income Trust Inc is a diversified investment fund with an investment objective to manage a portfolio of high-quality securities to achieve both preservations of capital and high monthly income. The trust seeks to achieve its investment objective by investing at least 65 percent of its assets in mortgage-backed securities. The Fund invests at least 80 percent of its assets in securities that are (i) issued or guaranteed by the U.S. government or one of its agencies or instrumentalities or (ii) rated at the time of investment either AAA by S&P Global Ratings (S&P) or Aaa by Moody's Investors Service, Inc (Moody's). The Fund may invest directly in such securities or synthetically through the use of derivatives.

Share on Social Networks: